previously, Aznar et al., showed that Daple/CCDC88C enables Wnt receptors to transactivate trimeric G-proteins during non-canonical Wnt signaling via a novel G-protein binding and activating (GBA) motif. By doing so, Daple serves two opposing roles; earlier during oncogenesis it suppresses neoplastic transformation and tumor growth, but later it triggers epithelial-to-mesenchymal-transition (EMT). We have identified and characterized two isoforms of the human Daple gene. While both isoforms cooperatively suppress tumor growth via their GBA motif, only the full-length transcript triggers eMt and invasion. Both isoforms are suppressed during colon cancer progression, and their reduced expression carries additive prognostic significance. These findings provide insights into the opposing roles of Daple during cancer progression and define the G-protein regulatory GBA motif as one of the minimal modules essential for Daple's role as a tumor suppressor.
Daple-V2 is the most abundant isoform that is expressed in both normal and tumor tissues. To determine how the expression of Daple isoforms change during normal to cancer progression, we analyzed the relative transcript expression of each Daple isoform in normal and tumor tissues annotated in the TCGA (The Cancer Genome Atlas) data portal using the web server-ISOexpresso. This server facilitates expression-based isoform-level analysis. Such analysis revealed that the cumulative levels of Daple transcripts are reduced from a median of 23.14 to 15.6 between normal colon and colorectal tumor tissues, respectively (Fig. 1C) , however, Daple-V2 remained the most abundant isoform (besides Daple-fl) in both cases ( Fig. 1D-F) .
When we expanded this analysis to include all 9,690 tumors and 732 normal controls of 30 cancer types annotated in the TCGA data portal, Daple-V2 still remained the most dominant isoform across all tissue types ( Supplementary Fig. 3A,B ). These findings indicate that Daple-V2 is the most abundant isoform of Daple (in normal and tumor tissues) that is translated into protein and has the minimal motifs/modules necessary to scaffold Dvl, FZD7 and G-proteins.
Validation of Daple-V2, a major isoform of Daple in cells. We first began by asking if the isolated
Daple-V2 gene product that we cloned, actually expressed as a protein. We found that is indeed the case; a product of predicted molecular weight was detected by immunoblotting in cells exogenously expressing the Daple-V2 construct using an antibody that was raised against Daple's C-terminus ( Fig. 2A ). Next we asked if Daple-V2 is expressed in cells (endogenous pool). Because all transcripts sharing the C-terminal GBA and PDZ-binding motifs share an identical 3′UTR (Fig. 1A) , we utilized a previously-validated 3′UTR-targeted shRNA approach to knockdown various isoforms of Daple in cells 1 . Full length immunoblots revealed that Daple-fl (~250 kDa) and several bands around the corresponding molecular weight of Daple-V2 (~70 kDa) are depleted in shDaple cells compared to shControl (Fig. 2B ). Because most of the bands observed ~70 kDa were depleted in shDaple cells, these may represent Daple-V2, its various posttranslational modified forms, and/or other transcript variants. Successful targeting of Daple-fl and Daple-V2 was further confirmed through measurements of mRNA transcripts by quantitative RT-PCR (qPCR). Compared to shControl cells, shDaple cells had a significant decrease in both full length and V2 isoforms (Fig. 2C,D) .
Next, we checked the expression of mRNA and protein of Daple-fl and Daple-V2 in normal adult colon. We analyzed mRNA levels of both Daple-fl and Daple-V2 in 14 colons samples by qPCR; both isoforms were detected ( Fig. 2E ). Furthermore, we confirmed the protein expression of Daple-fl and Daple-V2 ( Fig. 2F ) by analyzing lysates of mucosal biopsies taken from normal colons by immunoblotting using an anti-Daple-CT antibody raised against aa 1660-2028 ([previously validated in 1 and expected to detect both Daple-fl and -V2 isoforms).
Daple-V2 and Daple-fl have distinct subcellular localizations.
Prior work from our group demonstrated the importance of the N-terminal coiled-coil domain (which is absent in Daple-V2) in localizing Daple to the pericentriolar recycling compartment 11 . Therefore, we next asked if the two isoforms of Daple differs in its subcellular localization. As expected, transfection of mCherry tagged Daple-fl into HeLa cells revealed that the full-length protein localizes to a pericentriolar compartment, as determined by their proximity to the centrosomal marker γ-tubulin ( Fig. 3G ). By contrast, Daple-V2 is distributed ubiquitously throughout the cell and was seen even within the nucleus (Fig. 3E-G ). Immunoblotting using mCherry or Daple antibodies confirmed that the exogenously expressed Daple protein is stable and the observed localization is not due to degradation of the protein ( Supplementary Fig. 4) . Others have noted that localization of Daple can differ depending on the chemical fixative used 12 . We observed the contrasting localizations of Daple-fl and Daple-V2 regardless of whether cells were live or fixed with different fixatives, i.e., paraformaldehyde or methanol ( Fig. 3E-G) . These results indicate that the observed difference in the localization of Daple's isoforms is likely to be real. Because the subcellular localization of a signal transducer is a key determinant of the signals it modulates, our findings also suggest that differential localization of Daple-fl and Daple-V2 may translate to different functional roles in the cell, and some of those functions may be dictated by their compartmentalized actions.
Daple-V2 antagonizes Wnt signaling via the β-catenin/tcf/Lef pathway, suppresses growth and proliferation but does not trigger eMt or cell invasion. We previously demonstrated that
Daple-fl and more specifically its GBA motif, antagonizes the β-catenin-dependent Wnt signaling pathway and inhibits colony growth, but enhances the PI3K-Akt and Rac1 signals, EMT and invasion 1 . Because Daple-V2 possesses a GBA motif, and because the motif is required for binding G-proteins, we asked if this motif is functional in cells. Using DLD1 colon cancer cells stably expressing 7-TGP ( Fig. 4A) , an eGFP expressing Wnt activity reporter construct 1 , or parental DLD1 cells ( Fig. 4B ), we generated stable cell lines expressing Daple-V2 wild-type (WT) and GEF-deficient (F194A; FA) mutant. For comparison, we used previously developed and characterized 1 DLD1 lines expressing the Daple-fl-WT.
We found that Daple-V2 and Daple-fl have two similarities and one dissimilarity. First similarity was that both Daple-fl and Daple-V2 antagonize the β-catenin/TCF/LEF pathway (Fig. 4C) ; Daple-V2-WT, but not Daple-V2-FA, inhibited eGFP expression ( Fig. 4A,D) , indicating that the inhibitory effect of Daple-V2 on the canonical Wnt pathway required an intact GBA motif. Consistently, both Daple-fl and Daple-V2 reduced the transcription of downstream target genes Axin-2 and SFRP-1; once again, the presence of an intact GBA motif was critical for such inhibition (Fig. 4E ,F). Second similarity was that expression of either Daple-fl or Daple-V2 inhibited anchorage-dependent colony growth of DLD1 cells by ~50% and 90%, respectively ( Fig. 4G,H) . Such growth suppressive effect required an intact GBA motif because, compared to Daple-V2-WT, expression of the GBA-deficient F194A [ 1 corresponding to F1675 in Daple-fl; henceforth, FA] mutant not only failed to inhibit cell colony formation, but also enhanced anchorage-dependent growth (Fig. 4I,J) .
The dissimilarity between Daple-fl and Daple-V2 was observed in whether they used their GBA motifs to trigger EMT. Compared to cells expressing the GBA-deficient FA mutants of Daple-V2 or Daple-fl, those expressing Daple-fl WT had significantly higher expression of Lox-L3 and Vimentin, two genes commonly associated with epithelial-mesenchymal transition (EMT) ( Supplementary Fig. 5 ). Furthermore, in 3-D matrigel invasion assays using the transformed NIH3T3 cells, as done previously 1 , enhanced invasion, as determined by the area of invasion was detected exclusively in the presence of Daple-fl-WT, but not in cells expressing Daple-V2 or Daple-fl-FA, indicating that only Daple-fl can trigger cell invasion ( Fig. 4K ,L). We found that expression of Daple-fl, but not Daple-V2 is increased in the invading margins of tumors compared to the non-invasive tumor cores ( Fig. 4M,N) , which is in keeping with our findings that Daple-V2 does not contribute to EMT or higher invasiveness.
(corresponding to exon 30 of Daple-fl). (C-F) The expression level of various Daple (CCDC88C) transcripts in normal colon and colorectal cancer tissues annotated in The Cancer Genome Atlas (TCGA) Data Portal analyzed by ISOexpresso, a web-based platform (see Methods; http://wiki.tgilab.org/ISOexpresso/). Box plots (C) display the levels of expression of Daple in normal colon vs. tumor tissues expressed as TPM, Median transcripts per million; TPM was calculated by multiplying the median value of the estimates of the transcript in each sample group by one million. Bar graphs (D) display the relative abundance of each Daple transcript in normal vs tumor tissues. Box plots display the absolute abundance of each Daple transcript in normal colon (E) and colorectal tumor (F) tissues.
The ratio of Daple-fl and V2 isoforms shift when cells are exposed to Aspirin. Because both Daple isoforms can suppress the β-catenin/TCF/LEF pathway and anchorage-dependent colony growth, but only Daple-fl can induce EMT and invasiveness, we rationalized that tumor cells may regulate their expression differentially to their own advantage. To test if such is the case, we asked if levels of expression of Daple-fl and Daple-V2 change in response to Aspirin, a potent chemopreventive agent that reduces the risk of colorectal cancers (CRCs) by half 13, 14 . We found that the treatment of DLD1 cells with low-dose Aspirin reduces both mRNA and protein for Daple-fl ( Fig. 4O ,P), which has both tumor-suppressive and pro-metastatic properties. By contrast, Aspirin increased the mRNA and protein for Daple-V2 ( Fig. 4O ,P), which has only tumor-suppressive properties. Overall, the ratio of Daple-V2 to Daple-fl was increased. When we analyzed a panel of CRC cell lines representing diverse subtypes of CRCs and harboring different mutant driver oncogenes ( Supplementary Fig. 6A ), we found that the Aspirin-induced changes we observed in DLD1 cells was also observed in some other CRC cell lines, but not in all of them (Fig. 4Q ). The ratio of Daple-V2:fl was increased exclusively in those cell lines which were previously shown to be most sensitive to the growth suppressive action of Aspirin 15 , and share a common driver oncogene, PIK3CA ( Fig. 4Q, Supplementary Fig. 6 ). Whether these observed changes in Daple isoforms are due to Aspirin's ability to inhibit cyclo-oxygenase-II (COX2), i.e., COX2-dependent or independent mechanisms 13, 16 remain unknown. Regardless, what is clear is that these changes are consistent with Aspirin's ability to suppress polyp-to-cancer progression in the colon 17, 18 , as well as its ability to inhibit metastatic progression of advanced CRCs [19] [20] [21] .
Taken together, these findings demonstrate that compared to Daple-fl, Daple-V2 may serve as a more effective inhibitor of the β-Catenin-dependent canonical Wnt pathway and tumor growth in colonies, but it does not www.nature.com/scientificreports www.nature.com/scientificreports/ enhance EMT or invasion (Fig. 4R) , and that their expression may be differentially regulated by tumor cells to gain advantages in growth and invasiveness. Findings also reveal that Aspirin-mediated growth suppression is associated with an increase in the Daple-V2:Daple-fl ratio, and that such a change occurs exclusively in CRC cells harboring a constitutively activated PI3K-Akt pathway. . In both assays we found that co-expression of Daple-fl and Daple-V2 isoforms suppressed cell growth and proliferation more effectively than compared to either isoform alone ( Fig. 5B ,C).
We previously showed that Daple-fl is downregulated earlier during cancer initiation (at the stage of polyp to cancer conversion), and that its expression at high levels carries a good prognosis in CRCs 1 .We also showed that levels of Daple-fl is increased later during metastatic progression and in circulating tumor cells (CTCs), and that high levels of expression carry a worse prognosis. We asked if and how the expression of Daple-V2 changes during cancer progression in the colon and what, if any, may the prognostic impact of such changes. Once again, we found several similarities and one dissimilarity. Analysis by qPCR in 12 paired colorectal tumors and their adjacent normal tissue showed that, much like Daple-fl, the expression of Daple-V2 is decreased in CRCs (Fig. 5D ). When we analyzed a cohort of patients with Duke's Stage II CRCs, we found that tumors that express low Daple-V2 had a significantly higher incidence of oncogenic K-ras mutation ( Fig. 5E ; Table 1 ); no such correlation was seen in the case of Daple-fl. Tumors that express low Daple-fl ( Fig. 5F ) or low Daple-V2 ( Fig. 5G ) or low levels of both isoforms (Fig. 5H ) have a higher frequency of progression to distant metastases. Kaplan-Meier analyses revealed that Daple-V2 is a better prognosticator than Daple-fl (compare Fig. 5I -L) when used standalone to stratify risk for recurrence-free survival (RFS) and disease-specific survival (DSS). When accounting for high vs low levels of both Daple isoforms, an additive prognostic impact was seen compared to each alone (Fig. 5M,N) . A correlation analysis showed that Daple-V2, but not Daple-fl negatively correlates with the marker for proliferative index of tumor cells Ki67 22, 23 , and positive correlation with the tumor suppressor SAM and SH3-Domain Containing 1 (SASH1) 24, 25 (Table 2 ). Together with our findings on cell lines (growth curve, Wnt reporter and tumor cell colony formation assays), these analyses on patient tumors suggest that while both isoforms suppress tumor cell proliferation, Daple-V2 may be a more potent suppressor of tumor cell growth and proliferation than Daple-fl. These findings also define the profile of dysregulated Daple-fl and Daple-V2 expression during oncogenic progression in the colon: both isoforms are suppressed during colorectal cancer progression, and low expression levels of both isoforms alone or simultaneously exhibit decreased survival.
Finally, we previously discovered that high levels of expression of Daple in CTCs of patients with metastatic (Duke's Stage IV) CRCs is associated with poorer prognosis compared to those with low Daple in CTCs 7 ; high Daple is associated with higher tumor recurrence at distant sites and poorer survival. Here we asked how each isoform contributed to the prognostic impact using the same cohort. We found that Daple-fl,but not Daple-V2, levels of the housekeeping gene, GAPDH. Bar graphs display the fold change in each RNA normalized to the expression in cells expressing control vector. Error bars represent mean ± S.D of 3 independent experiments. (G-J) Monolayers of DLD1 cells in (B) were analyzed for their ability to form adherent tumor cell colonies on plastic plates during 2-3 weeks prior to fixation and staining with crystal violet. In panels G and I, photographs of representative wells of the crystal violet-stained 6-well plates are displayed. The number of colonies was counted by ImageJ (Colony counter). In panels (H,J), bar graphs display the # of colonies per well seen in each cell line in (G,I), respectively. Panels (G,H) show that both Daple-fl and Daple-V2 can inhibit tumor growth. Panels (I,J) show that the GBA motif of Daple-V2 is required for the inhibition of anchorage-dependent colony growth. (K,L) Spheroids (S) of NIH3T3 cells expressing WT or FA mutant of myc-Daple-fl or myc-Daple-V2 isoform were analyzed for their ability to invade matrigel in response to Wnt5a (100 ng/ml) using a Cultrex-3D Spheroid Invasion Kit (Trevigen). Representative images of spheroid edges are displayed (K). An increase of invasion tracks (arrowheads) was noted only from the edge of tumor spheroids formed by cells expressing myc-Daple-fl-WT, but not the GEF-deficient F1675A (FA) mutant. Neither the WT nor the FA mutant of Daple-V2 could trigger invasion. Area of invasion was quantified using ImageJ and displayed as bar graphs (L). expression is increased in disseminated tumor cells compare to healthy subjects (Supplemental Fig. 7A,B) . When we assessed their prognostic impact on survival, we found that although high expression of each isoform correlated with worse PFS ( Supplementary Fig. 7C,F) , only Daple-fl levels carried a prognostic impact for DSS and overall survival (OS) ( Supplementary Fig. 7D,E,G,H) . These findings are in keeping with our prior observations that pro-invasive and pro-EMT signatures are triggered exclusively by Daple-fl, but not Daple-V2 (Fig. 2Q ).
From these results we deduce that both Daple-fl and Daple-V2 cooperatively suppress tumor cell proliferation, that both transcripts are reduced during adenoma-to-carcinoma progression, and that the two isoforms have an additive prognostic impact, in that their reduced expression in tumors carries a poor prognosis. However, the two isoforms differ in their ability to trigger EMT and invasion; Daple-fl, but not Daple-V2 can support that. Table 1 . Bar graphs display the incidence (expressed as %) of K-Ras mutation (Y axis) when either Daple isoforms are either high or low. Red and blue colors indicate whether the tumors harbored oncogenic mutant or WT copy of K-Ras, respectively. The incidence of mutation is displayed on the top of each bar. Tumors with low Daple-V2 had a significant chance that they also harbor mutant K-Ras. No such relationship was seen between levels of expression of Daple-fl and mutant K-Ras. 
Daple is downregulated during adenoma-to-carcinoma conversion. Next we asked if suppression
of Daple-fl and Daple-V2 transcripts during adenoma-to-cancer progression is also associated with reduced Daple proteins. Using an antibody raised against the C-terminus of Daple, which is identical between Daple-fl and Daple-V2, we confirmed that total Daple is expressed in the normal colon and in early and intermediate adenomas, but it is suppressed in advanced adenomas with villous features or high-grade dysplasia (Fig. 6A,B) . In cancers, ~60% expressed Daple, but ~40% did not.
Taken together, our findings support the following model ( Fig. 6C ). While both Daple-fl and Daple-V2 isoforms serve as growth suppressors early during oncogenesis, only Daple-fl serves as a pro-metastatic protein later during cancer progression. While both are suppressed during the step of polyp-to-cancer conversion, only Daple-fl is induced later during cancer invasion and dissemination.
conclusions
The major discovery we report here is the identification and characterization of a novel physiologic isoform of Daple, Daple-V2, which appears to contain the minimal modules that enable Daple to antagonize canonical β-Catenin-dependent Wnt signals and inhibit tumor cell growth and proliferation. Both isoforms are reduced during polyp-to-cancer progression in the colon. Compared to Daple-fl, Daple-V2 appears to be a more potent tumor suppressor and a better prognostic marker in primary tumors.
What Daple-V2 lacks is the ability to trigger EMT and invasion, which is a feature unique to Daple-fl. Consistent with these findings, we also found that although both isoforms collaboratively suppress tumor cell growth, and have an additive prognostic impact, only Daple-fl is increased in invasive margins and in CTCs disseminated during metastatic progression. Because we previously showed that a functional GBA motif is essential for Daple-fl to trigger EMT and invasion 1 , that Daple-V2 cannot trigger EMT despite a functionally intact GBA suggests that these functions not only require the coupling of Daple's C-terminus to G-proteins, but also the functions of its N-terminal HOOK and coiled-coil domains, e.g., phosphoinositide (PI3P) binding and localization to the pericentriolar recycling endosomes 11 , or binding to the dynein-dynactin motor complex 26 .
Although it remains unknown how cells modulate the expression of each Daple isoform, our studies provided precious clues. When exposed to the chemoprevention drug, Aspirin, CRC cells that are sensitive to its growth-suppressive action were able to suppress Daple-fl but concomitantly increased Daple-V2; this effect was observed only in CRC cell lines that harbor the PIK3CA mutation. Prior clinical trials in humans 27, 28 and studies on cultured cells 15, 29 have confirmed that CRCs/cells that harbor PIK3CA mutation are most sensitive to the growth-suppressive action of Aspirin. Based on the properties of each isoform, we conclude that such a tradeoff is expected to overall maximize the desirable tumor-suppressive effect of Daple without the undesirable pro-EMT and pro-invasive effects. In fact, a decrease in the levels of Daple-V2 with a concomitant increase in Daple-fl transcripts in the circulating blood has recently been shown to correlate with increased stemness markers, an aggressive disease course and a shorter relapse-free survival in patients with melanoma 30 . www.nature.com/scientificreports www.nature.com/scientificreports/ Despite the insights gained, a lot remains unknown. For example, it is possible that the mRNA for Daple-V2 isoform could have cellular functions independently of protein expression. Similarly, the numerous other splice variants, including those not interrogated here, may contribute to a rich complex of Daple biology in cancer.
In conclusion, we have revealed one of perhaps many ways how expression of Daple and its functions are regulated in the colon. Our findings that Daple isoforms can be pharmacologically manipulated to selectively augment its tumor-suppressive functions, while suppressing its pro-metastatic functions raises hope that therapeutic strategies could be tailored to meet such goals.
Materials and Methods
Reagents and antibodies. Unless otherwise indicated, all reagents were of analytical grade and obtained from Sigma-Aldrich. Cell culture media were purchased from Invitrogen. All restriction endonucleases and Escherichia coli strain DH5α were purchased from New England Biolabs. E. coli strain BL21 (DE3) and phalloidin-Texas Red were purchased from Invitrogen. Genejuice transfection reagent was from Novagen. PfuUltra DNA polymerase was purchased from Stratagene. Recombinant Goat anti-rabbit and goat anti-mouse Alexa Fluor 680 or IRDye 800 F(ab′)2 used for immunoblotting were from Li-Cor Biosciences. Mouse anti-α-tubulin and anti-actin were obtained from Sigma; anti-Myc was obtained from Covance, and anti-GFP from Santa Cruz Biotechnology. Rabbit anti-pan-Gβ (M-14), and anti-Gαi3 were obtained from Santa Cruz Biotechnology. Anti-Daple antibodies were generated in collaboration with Millipore using the C-terminus of Daple (1660-2028 aa) as an immunogen. WNT proteins were purified from 6 liters of CHO CM. CM was complemented with 1% Triton X-100 (vol/vol), 20 mM Tris-Cl pH 7.5, and 0.01% NaN 3 . Daple-fl was carried out as described previously 1, 11 . The subsequent site-directed mutagenesis and truncated constructs (myc-Daple full length F1675A (FA) and deleted from 2025-2028 aa (ΔPBM) were carried out on this template using Quick Change as per manufacturer's protocol. Cloning of N-terminally tagged myc-Daple-V2 was carried out by PCR cloning directly from HeLa cDNA using primers containing the unique 5′ region (MSVLS) in Daple V2 sequence (corresponding to UniProtKB -Q9P219-2) and being inserted into myc-pcDNA 3.1 (+) between Kpn-1/EcoR1. To clone mCherry Daple-V2, Daple-V2 was PCR amplified from HeLa cDNA with primers flanked with recombination site for Gateway cloning system (Invitrogen), as previously described 11 . Daple-V2-FA (F194A) and Daple-V2-ΔPBM (deleted from 549-552aa) were also directly cloned out from pcDNA3.1(+)-Daple-fl-FA and pcDNA3.1(+)-daple-fl-ΔPBM. Cloning of rat Gα-proteins into pGEX-4T-1 GST-Gαi3 has been described previously [31] [32] [33] [34] [35] . GST-tagged FZD7-CT construct 36 was a generous gift from Ryoji Yao (JFCR research institute, Japan). GST-Dvl2-PDZ was from Raymond Habas (Temple University, Philadelphia, PA).
Protein expression and purification. GST, GST-Gαi3, GST-PDZ and GST-FZD7 fusion constructs were expressed in E. coli strain BL21 (DE3) (Invitrogen) and purified as described previously [31] [32] [33] . Briefly, bacterial cultures were induced overnight at 25 °C with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). Pelleted bacteria from 1 L of culture were re-suspended in 10 ml GST-lysis buffer [25 mMTris-HCl, pH 7.5, 20 mMNaCl, 1 mM EDTA, 20% (v:v) glycerol, 1% (v:v) Triton TX-100, 2X protease inhibitor cocktail (Complete EDTA-free, Roche Diagnostics]. After sonication (4 × 20s, 1 min between cycles), lysates were centrifuged at 12,000 g at 4 °C for 20 min. Except for GST-FZD (see in vitro GST pulldown assay section), solubilized proteins were affinity purified on glutathione-Sepharose 4B beads (GE Healthcare). Proteins were eluted, dialyzed overnight against PBS and stored at −80 °C. cell culture and the rationale for choice of cells in various assays. Tissue culture was carried out essentially as described before 31, 32, 37 . We used a total of 3 different cell lines in this work, each chosen carefully based on its level of endogenous Daple expression and the type of assay. All these cell lines were cultured according to ATCC guidelines. Cos7 cells were primarily used for transient overexpression of tagged Daple protein and lysates of these cells were used as source of proteins in pulldown assays. We chose to carry out these assays in Cos7 cells because they are easily and efficiently transfected (>90% efficiency) with most constructs. The added advantage is that they have no detectable endogenous Daple and provide a system to selectively analyze the properties of WT vs mutant Daple constructs without interference from endogenous Daple.
DLD1 were primarily used to study the effect of Daple on cancer cell growth properties (anchorage-dependent) and to assess the effect of Daple on the classical Wnt signaling pathway (βCatenin/TCF/LEF). There are several reasons why this cell line was chosen: (1) We focused on colorectal cancer in this study and DLD1 cells were appropriate to translate our findings because they are human colorectal cancer cells; (2) We determined that levels of Daple are significantly lower/undetectable (~10 fold) in these cells compared to normal colon (data not shown), thereby allowing us to reconstitute Daple expression exogenously and analyze the effect of various mutant Daple constructs without significant interference due to the endogenous protein; (3) These cells have been extensively characterized with respect to most oncogenes (ATCC database), and are highly tumorigenic in 2-D and 3-D cultures due to a mutation in KRAS (G13D) (Shirasawa et al., 1993; Ahmedet al., 2013); (4) They are a sensitive model to study how various manipulations of the noncanonical Wnt signaling pathway oppose the canonical Wnt pathway during tumor growth because they constitutively secrete Wnt ligands to maintain high levels of the canonical signaling 38 within the growth matrix. Production and secretion of endogenous ligands bypasses the need to add exogenous ligands repeatedly during prolonged assays that last ~2 weeks.
Low passage NIH3T3 fibroblasts were used exclusively in 3-D Matrigel invasion. The rationale for their use in invasion assay lies in the fact that non-transformed NIH3T3 fibroblasts are poorly invasive in vitro and non-tumorigenic and non-metastatic in animal studies [39] [40] [41] [42] . It is because of this reason, NIH3T3 cells are widely used to study proteins that can trigger a gain in invasive properties 43 . The rationale for using NIH3T3 in the above assays is further strengthened by the fact that they are highly transfectable (~80% transfection efficiency with myc-Daple) and express Daple at very low endogenous levels (as determined by immunoblotting and qPCR) compared to normal colonic epithelium. Such expression pattern allows us to study the effect of various Daple mutant constructs without significant interference due to the endogenous protein. Multiple other CRC cell lines used in this work were obtained from ATCC and cultured as recommended.
transfection; generation of stable cell lines and cell lysis. Transfection was carried out using
Genejuice (Novagen) for DNA plasmids following the manufacturers' protocols. DLD1 cell lines stably expressing Daple constructs were selected after transfection in the presence of 800 μg/ml G418 for 6 weeks. The resultant multiclonal pool was subsequently maintained in the presence of 500 μg/ ml G418. Daple expression was verified independently using anti-Daple antibody by immunoblotting and estimated to be ~5x the endogenous level.
Quantitative immunoblotting. For immunoblotting, protein samples were separated by SDS-PAGE and transferred to PVDF membranes (Millipore). Membranes were blocked with PBS supplemented with 5% non-fat milk (or with 5% BSA when probing for phosphorylated proteins) before incubation with primary antibodies. Infrared imaging with two-color detection and band densitometry quantifications were performed using a Li-Cor Odyssey imaging system exactly as done previously 32, 34, 35, 37, 44 . Full length blots are provided in Fig. 2 and Supplementary Fig. 4 for endogenous and overexpressed exogenous Daple constructs. For all other instances, PVDF membrane was cut into strips for incubation with various antibodies (primary and secondary) www.nature.com/scientificreports www.nature.com/scientificreports/ to rigorously examine all antigens (phospho vs total target protein and loading controls) on the same gel/membrane to be reflective of balanced loading of samples. Cropped gels are indicated by borders. All Odyssey images were processed using Image J software (NIH) and assembled into figure panels using Photoshop and Illustrator software (Adobe). isoform expression analysis. These analyses were carried out using a web server, ISOexpresso 45 , which facilitates expression-based isoform-level analysis of RNA sequencing data from 9,690 tumors and 732 normal controls of 30 cancer types from TCGA (The Cancer Genome Atlas) Data Portal. Transcripts are matched to gene and isoform information based on hg19/GRCh37 including IDs of genes and isoforms, genomic location, and known canonical/principal isoforms from UCSC Annotation database, UniProt (Universal Protein Resource), RefSeq (NCBI Reference Sequence Database),Ensembl, CCDS (Consensus CDS), APPRIS (Annotating principal splice isoforms), and HGNC (HUGO Gene Nomenclature Committee).We performed the analysis using the server's 'Isoform Expression View function' which allows the analysis of tissue-specific RNA expression patterns of isoforms by selecting one or more tissues (cancer types) and querying a gene of interest.
In vitro GSt pulldown. Purified GST alone, GST-Gαi3 or GST-PDZ (5 µg) were immobilized on glutathione-Sepharose beads and incubated with binding buffer [50 mM Tris-HCl (pH 7.4), 100 mM NaCl, 0.4% (v:v) Nonidet P-40, 10 mM MgCl 2 , 5 mM EDTA, 30 µM GDP, 2 mM DTT, protease inhibitor mixture] for 90 min at room temperature as described before 31, 32, 37, 46 . Lysates (~250 µg) of Cos7 cells expressing appropriate myc-Daple-V2 constructs were added to each tube, and binding reactions were carried out for 4 h at 4 °C with constant tumbling in binding buffer [ GST-FZD7-CT construct was immobilized on glutathione-Sepharose beads directly from bacterial lysates by overnight incubation at 4 °C with constant tumbling as described before 1 . Next morning, GST-FZD7-CT immobilized on glutathione beads were washed and subsequently incubated with His-tagged Daple-CT or Gαi3 proteins at 4 °C with constant tumbling. Washes and immunoblotting were performed as previously. β-Catenin reporter assays. These assays were carried out using the well-established reporter 7xTcf-eGFP(7TGP) 47 . Stable cells lines expressing this reporter were generated by lentiviral transduction and subsequent selection using standard procedures. Lentiviral infection and selection were performed according to standard procedures. Briefly, 10 cm plates DLD1 cells at 70% confluency were incubated with media containing 8 µg/mL polybrene and 10 µl of lentivirus for 6 h. After 24 hours post infection, selection of puromycin-resistant clones was initiated by adding the antibiotic at 2 µg/ml final concentration. The resultant DLD1-7TGP stable cells were subsequently transfected with various myc-Daple V2 constructs and selected for G418 resistance as described earlier in methods. The DLD1-7TGP cells stably expressing myc-Daple were incubated overnight at 0.2% FBS, analyzed by fluorescence microscopy, and photographed prior to lysis. Whole cell lysates samples were then boiled in Laemmli's sample buffer and GFP protein expression was monitored by immunoblotting. cell proliferation assays. Two complementary methods were used. For cell counting assays, cells were seeded at 1 × 104 per well in Ham's F12 media with 10% (v/v) FBS and grown at 37 °C in a humidified 5% CO 2 incubator. At various times cells were trypsin released and manually counted with a haemocytometer. Results are means ± SEM (n = 3). For cell viability assays, cells were seeded into 96-well plates at 2 × 10 5 cells/ml and cultured in DMEM/Ham's F12 media supplemented with 2% FBS for 1-5 days. Cell growth was documented every 24 hours via a colorimetric assay using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma). Absorbance values were collected at 490 nm using a SpectraMax 190 microplate reader (Molecular Devices, Sunnyvale, CA, USA). Control samples were treated with vehicle (0.1% DMSO or ethanol in DMEM/ Ham's F12 culture media). In each individual experiment, proliferation was determined in triplicate, and the overall experiment was repeated at least three times.
Anchorage-dependent colony growth assay. Anchorage-dependent growth was monitored on solid (plastic) surface. Approximately ~1000 DLD1 cells stably expressing various Daple constructs were plated in 6-well plates and incubated in 5% CO 2 at 37 °C for ~2 weeks in 0.2% FBS growth media. Colonies were then stained with 0.005% crystal violet for 1 h. The remaining DLD1 cells were lysed and analyzed by WB to confirm Daple construct expression. Each experiment was analyzed in triplicate. invasion assays. NIH3T3 cell invasion assay in 3D culture was performed according to the manufacturer's protocol (Trevigen, Cultrex 3D Spheroid BME Cell Invasion Assay, catalog #3500-096-K). Briefly, NIH3T3 cells (3000 cells) transfected with empty vector (control) or myc-Daple constructs were incubated first in the Spheroid Formation extracellular matrix (ECM) containing 0.2% FBS for 3 days. Invasion matrix was then added and layered on top with media containing FBS. Serum-triggered cell invasion was photographed under light microscope every day for 10 days and fresh media (FBS concentration is increased each time in order to maintain a gradient) was replenished every 48 hours. Photographs were analyzed and pseudocolored by Image J to reflect cell density.
www.nature.com/scientificreports www.nature.com/scientificreports/ DAPLE: hDaple-fl-fwd: 5′-TGA CAT GGA GAC CCT GAA GGC TGA-3′ hDaple fl-rev2: 5′-TTTCATGCGGGCCTCACTGCTGA-3′ hDaple V2-Fwd: 5′-GTT GTC ACA CTC CCT GGA CCA TTT C-3′ hDaple V2-Rev: 5′-GCTTTGGTTTTAGATCCCCAGGGC-3′ patient cohort for iHc analysis. Formalin-fixed paraffin embedded (FFPE) normal, polyp and cancer tissues used in this study were obtained from patients undergoing routine colonoscopies and provided by the section of Gastroenterology, VA San Diego Healthcare System. The protocol was approved by the Human Research Protection Program Institutional Review Board (IRB; protocol H130266). These studies abide by the Declaration of Helsinki principles.
immunohistochemistry. Colon specimens of known histologic type were analyzed by IHC using a previously-validated anti-Daple-CT rabbit polyclonal antibody raised against Daple (1660-2028 aa) (1:50; Millipore Inc.). Briefly, formalin-fixed, paraffin-embedded tissue sections of 4 µm thickness were cut and placed on glass slides coated with 3-aminopropyl triethoxysilane, followed by deparaffinization and hydration. Heat-induced epitope retrieval was performed using citrate buffer (pH 6) in a pressure cooker. Tissue sections were incubated with 3% hydrogen peroxidase for 15 min to block endogenous peroxidase activity, followed by incubation with primary antibodies overnight in a humidified chamber at 4 °C. Immunostaining was visualized with a labeled streptavidin-biotin using 3,3′-diaminobenzidine as a chromogen and counterstained with hematoxylin. All the samples were first quantitatively analyzed and scored based on 2 independent criteria. First, the intensity of staining was scored on a scale of 0 to 3, where 0 = no staining, 1 = light brown, 2 = brown, and 3 = dark brown. Second, the percentage of the cells that stained positive in the tumor area was scored on a scale of 0 to 4, where 0 = 0, 1 = ≤10%, 2 = 11-50%, 3 = 51-75%, and 4 = >75%. Subsequently, each tumor sample was assigned a final score, which is the product of its (intensity of staining) × (% cells that stained positive). Tumors were categorized as negative when their final score was <3 and as positive when their final score was ≥3.
Statistical analyses.
Statistical evaluation was performed using GraphPad Prism 5 software. Unless stated otherwise, statistical significance was determined using Student's t test. The associations between the expression level of Daple isoforms and K-ras mutation status and metastatic status of disease were investigated by Fisher's exact test. Parametric Pearson's correlation and nonparametric Spearman's correlation analysis were used to assess the relationship between the expression of Daple isoforms and patients' age, tumor size, differentiation and grading, the level of Ki67-Index, Osteopontin, SASH1, MACC1 and CEA. In order to derive optimal cut-off values of gene expression levels, maximally selected log-rank statistics performed by Cutoff Finder (R Software version 2.15.0.) 49 were used. Time-dependent survival probabilities were estimated with the Kaplan-Meier method using the log-rank test. All statistical tests were performed two-sided, and p-values less than 0.05 were considered to be statistically significant.
